University at Buffalo - The State University of New York
Skip to Content
Kazuaki                        Takabe

Kazuaki Takabe 

Department of Surgery

Professor of Oncology, Alfiero Foundation Chair and Clinical Chief of Breast Surgery

 

Education and Training:
  • Fellowship, Virginia Commonwealth University (2008)
  • Residency, University of California San Diego (2006)
  • Internship, University of California San Diego (2002)
  • PhD, Yokohama City University Graduate School of Medicine (1999)
  • Residency, Niigata University Hospital (1995)
  • MD, Niigata University School of Medicine (1992)
Employment:
  • Chair and Clinical Chief of Breast Surgery, Surgery, Roswell Park Cancer Institute (2016-present)
  • Visiting Professor, Tokyo Medical University School of Medicine (2016-present)
  • Visiting Professor, Yokohama City University School of Medicine (2016-present)
  • Tenured, Surgery, Virginia Commonwealth University (2016-present)
  • Associate Professor, Surgery, Virginia Commonwealth University (2013–2016)
  • Assistant Professor, Biochemistry & Molecular Biology, Virginia Commonwealth University (2008–2013)
Awards and Honors:
  • First Place of G. Watson James Research Abstract Award (2016)
  • Outstanding Speaker, Cancer Biology (2015)
  • First Prize Winner of Basic Science category Cancer Paper Competition (2015)
  • Presenter at the Surgical Forum of Annual Surgical Congress (2014)
  • Scholarship for 2014 Geisel Leadership Course (2014)
  • The Best Basic Research Award (2014)
  • Second Prize Winner - Basic Science Research (2014)
  • Third Prize Winner of Poster Presentation Competition (2014)
  • First Prize Winner of Basic Science category Cancer Paper Competition (2014)
  • Second Place winner of Bigger-Lehman Award (2014)
  • James D. Popp Summer Research Fellowship (I.A. Woelfel) (2014)
  • 2013 SERLC Oral Presentation Travel Award, 48th Annual Southeastern Regional Lipid Conference (M. Nagahashi) (2013)
  • Elizabeth Fries Young Investigator Award, VCU Institute for Women’s Health, Women’s Health Research Day (A. Yamada) (2013)
  • Clinical Research Award, VCU Institute for Women’s Health (2013)
  • James D. Popp Summer Research Fellowship (S. DeMasi) (2013)
  • 16th Yujin Memorial Young Investigator Award (2012)
  • Winner - VCU Dep of Surgery Resident Paper Competition (B.J. Adams) (2012)
  • First Prize Winner of Basic Science category Cancer Paper Competition (2012)
  • Second Place winner of Bigger-Lehman Award (2012)
  • David M. Hume Memorial Resident Presentation (2012)
  • Elizabeth Fries Young Investigator Award, VCU Institute for Women’s Health, 8th Annual VCU Women’s Health Research Day (M. Nagahashi) (2012)
  • Basic Science Award, VCU Institute for Women’s Health (2012)
  • First Place - Clinical & Translational Research Category (2012)
  • Excellence in Cancer Research Award (First Place) (2011)
  • Excellence in Research Award in Targeted Therapies category (2011)
  • 2011 ICAMS/LCRD Research Retreat – Outstanding Presentation (2011)
  • 2011 ICAMS/LCRD Research Retreat – Outstanding Presentation (2011)
  • First Prize Winner - Basic Science Research (2011)
  • Winners - VCU Dep of Surgery Resident Paper Competition (2011)
  • Best Basic and Translational Research Poster (2011)
  • Spring Semester Travel Award, VCU Postdoctoral Association (2011)
  • Patients’ Choice Award (2011)
  • Fellow of American College of Surgeons (2010)
  • First Prize Winner - Basic Science Research (2010)
  • Photo Contest Winner (2009)
  • First Prize - Residents Papers Competition (2009)
  • Patients’ Choice award (2009)
  • First Prize - Cancer Basic Research Paper Competition (2009)
  • Finalist Best Poster Contest at 62nd Annual Cancer Symposium (2009)
  • 2nd Prize Winner - Basic Science Research (2008)
  • One of America’s Top Surgeons (2007)
  • First Prize Winner of Resident Paper Competition (2007)
  • First Prize Winner of Resident Paper Competition (2006)
  • 9th Yujin Memorial Young Investigator Award (2005)
  • Surgical Forum Presenter (2004)
  • Surgical Forum Presenter (2003)
  • Third Prize, 342th Sankei Paper Competition “My Medical Reform” (2003)
  • Prize Winner (2003)
  • First Prize Winner (2002)
  • Who's Who in America (2002)
  • President’s Choice Poster Presentation (1999)
  • Third prize (1992)

Grants and Sponsored Research:
  • December 2015–November 2020
    Role of Tumor &/or Host Sphingosine-1-Phosphate in Hem-&lymphangiogenesis
    Susan G. Komen
    Role: Principal Investigator
    $180,000
  • December 2015–November 2020
    Bile Acid and Sphingosine -1- phosphate Receptor-mediated Signaling in Cholestasis
    NIH/National Institute of Digestive Disease and Kidney
    Role: Co-Investigator
    $37,475
  • February 2012–June 2017
    Regulation of hepatic SphK2 by bile acids: effects on lipid metabolism
    NIH/National Institute of Digestive Disease and Kidney
    Role: Co-Investigator
    $11,661
  • July 2012–April 2017
    Sphingosine-1-phosphate in breast cancer progression and lymphangiogenesis
    NIH/National Cancer Institute TME
    Role: Principal Investigator
    $1,008,785
  • –May 2015
    Manipulation of Sphingosine-1-phosphate signaling as a novel approach for enhancing immune checkpoint targeted therapy for breast cancer lung metastasis
    Massey Cancer Center
    Role: Principal Investigator
    $3,000
  • July 2011–April 2015
    Regulation of caspase 9 RNA splicing in NSCLC cancer
    NIH/National Cancer Institute
    Role: Co-Investigator
    $4,600
  • –March 2015
    The role of Sphingosine-1-phosphate in the breast cancer lung metastasis and prognosis
    The James D. Popp Student Research Fund
    Role: Contributor
    $5,000
  • February 2014–January 2015
    Role of mitochondrial Stat3 in breast cancer growth and progression
    Massey Cancer Center
    Role: Co-Investigator
    $100,000
  • November 2013–June 2014
    The S1P signaling pathway as a novel therapeutic target for advanced colorectal cancer
    NIH/T32 Postdoctoral Training Award
    Role: Consultant
  • April 2012–April 2014
    The role of sphingosine-1-phosphate in obesity-mediated breast cancer progression
    Japan Society for the Promotion of Science
    Role: Contributor
    $100,000
  • –April 2014
    Targeting S1P signaling for pancreatic cancer peritoneal carcinomatosis
    Massey Cancer Center
    Role: Principal Investigator
    $5,000
  • –March 2014
    The role of sphingosine-1-phosphate in colon cancer peritoneal carcinomatosis
    The James D. Popp Student Research Fund
    Role: Contributor
    $5,000
  • –January 2014
    Ceramide kinase, UVRAG, and ceramide-1-phosphate: The triumvirate of breast cancer metastasis?
    VCU Massey Cancer Center
    Role: Co-Investigator
  • –July 2013
    Targeting the S1P Axis and Development of a Novel Therapy for Obesity-Related Triple Negative Breast Cancer
    Department of Defense
    Role: Contributor
    $7,215
  • –January 2013
    Targeting the sphingosine-1-phosphate axis: Potential new therapy for obesity-related breast cancer
    VCU Massey Cancer Center
    Role: Co-Principal Investigator
  • October 2009–September 2012
    Sphingosine Kinase 1 as a New Target for Systemic Therapy against Breast Cancer Development and Characterization of Novel Sphingosine Kinase 1 Inhibitor
    Susan G. Komen for the Cure; Career Catalyst Research Grant
    Role: Principal Investigator
    $450,000
  • April 2012–July 2012
    Sphingosine-1-phosphate in breast cancer progression and lymphangiogenesis
    VCU School of Medicine
    Role: Principal Investigator
    $50,000
  • January 2008–July 2012
    Role of ABC Transporters in Sphingosine Kinase Induced Tumorigenicity of Breast Cancer
    NIH/National Institute of Child Health and Human Development
    Role: Contributor
    $500,000
  • April 2009–March 2011
    Role of Sphingosine-1-phosphate in cancer
    Sumitomo Life Social Welfare Services Foundation
    Role: Contributor
    $18,750
  • July 2007–June 2008
    Signaling in Tissue Injury and Repair
    NIH/National Institute of General Medical Sciences
    Role: Contributor
    $54,002
  • July 2006–June 2008
    Neoadjuvant Chemotherapy for Breast Cancer, Correlating Response with Gene Expression Profiles and MTA 1 Expression.
    V-Foundation
    Role: Co-Investigator
  • April 2001–June 2001
    The role of activin in liver regeneration
    Gail I. Zucherman Foundation Funds
    Role: Principal Investigator
    $20,000
  • September 1997–July 2000
    Research Fellowship at the Salk Institute for Biological Studies
    Yoshida Scholarship Foundation
    Role: Principal Investigator
    $110,000
  • March 2014
    Role of mitochondrial Stat3 in breast cancer growth and progression
    Massey Cancer Center
    Role: Co-Investigator
    $27,000
See all (14 more)

Evaluative Studies and Case Reports:
Journal Articles:
See all (73 more)
Abstracts:
  • Nagahashi M., Tsuchida J., Moro K., Tatsuda K., Koyama Y., Takabe K, Wakai T.. Sphingosine-1-phosphate signaling promotes metastatic niches and lung metastasis in obesity-related breast cancer.. Cancer Research. 2016; 76(4).
  • Tsuchida J., Nagahashi M., Moro K., Tatsuda K, Koyama Y., Takabe K, Wakai T.. Obesity increases the lipid mediator, sphingosine-1-phosphate in the tumor and tumor microenvironment, and promotes tumor progression.. Cancer Research. 2016; 76(4).
  • Aoki H., Aoki M., Katsuta E., Fernandez LJ., Mukhopadhyay P., Barnett C., Spiegel S., Takabe K. Conjugated Bile Acid Promote the Proliferation of Pancreatic Cancer via Sphingosine 1-Phosphate Receptor.. Annals of Surgical Oncology. 2016.
  • Aoki H., Aoki M., Mukhopadhyay P., Barnett C., Spiegel S., Takabe K. Inflammation Induced by Sphingosine Kinase of the Host Aggravates Pancreatic Cancer Peritoneal Carcinomatosis.. Annals of Surgical Oncology. 2016; 23(1).
  • Katsuta E., DeMasi S., Terracina KP., Aoki H., Aoki M., Mukhopadhyay P., Spiegel S., Takabe K. How Fast Can the Immune Response Eliminate Murine Cancer Cells from a Different Background?. Annals of Surgical Oncology. 2016; 23(1).
  • Takabe K, Nagahashi M., Spiegel S.. Sphingosine-1-phosphate Signaling Targeted by FTY720 Suppress Obesity-related Breast Cancer Progression, Metastasis and Improve Survival.. Annals of Surgical Oncology. 2016; 23(1).
  • Hait NC., Avni D., Yamada A., Milstien S., Takabe K, Spiegel S.. FTY720-P is a potent inhibitor of class I histone deacetylases that enhances histone acetylation, reactivates ERa expression, and increases hormonal therapeutic sensitivity of breast cancer.. Cancer Research. 2015; 75(15).
  • Aoyagi T., Avni D., Nagahashi M., Yamada A., Terracina KP., Huang WC., Aoki K., Spiegel S., Matsubara H., Takabe K. FTY720 suppressed CT26 murine colon cancer peritoneal carcinomatosis progression by decreasing tumor associated macrophages and TNF-alpha.. Cancer Research. 2015; 75(15).
  • Terracina KP., Aoyagi T., Huang W., Yamada A., Nagahashi M., Takabe K. Modified Orthotopic Murine Colon Cancer Cell Implantation Method that Mimics Clinical Cancer Progression.. Annals of Surgical Oncology. 2015; 22(1).
  • Fernandez LJ., Wolen AR., Olex AL., Dozmorov MG., Fenstermacher DA., Takabe K. Is patient derived xenograft model appropriate for colon cancer preclinical drug development?. Annals of Surgical Oncology. 2015; 22(1).
  • Terracina KP., Aoyagi T., Huang W., Yamada A., Nagahashi M., Takabe K. Improvements to a Murine Colon Cancer Model for Cancer Progression and the Tumor Microenvironment.. Journal of Surgical Research. 2015.
  • Woelfel IA., Terracina KP., Lima S., Oyeniran C., Mukhopadhyay P., Aoki H., Avni D., Hait NC., Newton J., Wu X., Yamamoto H., Spiegel S., Takabe K. Gene silencing of SphK1 with nanoparticles as an innovative approach against cancer progression.. Journal of Surgial Research. 2015.
  • Aoki H., Raza A., Mukhopadhyay P., Terracina KP., Barnette CC., Spiegel S., Takabe K. Role of sphingosine kinase 1 of the host in the progression of pancreatic cancer peritoneal carcinomatosis.. Journal of Surgical Research. 2015.
  • Fernandez L., Huang WC., Terracina KP., Yamada A., Aoyagi T., Nagahashi M., Spiegel S., Takabe K. S1P Forms a Feed-Forward Loop with the Ang2 and VEGF-C Pathways in Lymphangiogenesis.. Journal of Surgical Research. 2015.
  • Fernandez L., Huang WC., Terracina KP, Nagahashi M., Yamada A., Aoyagi T., Spiegel S., Takabe K. Role of Sphingosine-1-Phosphate in Inflammation-Induced Lymphangiogenesis.. Journal of Surgical Research. 2015.
  • Meier J., Raza A., Yamada A., Dai Y., Chen S., Grant S., Takabe K, Larner A.. 107 STAT3 interacts with Cyclophilin D in cancer cells to regulate the mitochondrial permeability transition pore.. Cytokine. 2014; 70(1).
  • Aoyagi T., Avini D., Nagahashi M., Yamada A., Terracina KP., Huang WC., Soong J., Idowu MO, Aoki K., Milstien S., Spiegel S., Takabe K. FTY720 as a novel therapeutic approach for colon cancer carcinomatosis.. Cancer Research. 2014; 74(19).
  • Yamada A., Nagahashi M., Aoyagi T., Huang WC., Terracina KP., Allegood JC., Lima S., Milstien S., Spiegel S., Kida K., Ishikawa T., Endo I., Takabe K. Activated SphK1 and export of S1P via ABCC1 shorten disease free survival in breast cancer.. Cancer Research. 2014; 74(19).
  • Nagahashi M., Yamada A., Miyazaki H., Allegood JC., Aoyagi T., Huang WC., Terracina KP., Milstien S., Spiegel S., Takabe K. Determination of sphingosine-1-phospate levels in tissue interstitial fluid and lymphatic fluid utilizing novel collection techniques.. Cancer Research. 2014; 74(19).
  • Nagahashi M., Yamada A., Aoyagi T., Terracina KP., Koyama Y., Wakai T., Takabe K. Sphingossine-1-Phosphate Signaling Targeted Therapy Suppresses Obesity-Related Breast Cancer Progression and Improves survival.. Journal of the American College of Surgeons. 2014.
  • Nagahashi M., Liang J., Yamada A., Huang WC., Koyama Y., Wakai T., Milstien S., Spiegel S., Takabe K. FTY720, a Sphingosine-1-phosphate receptor modulator, as a novel targeted therapy against colitis-associated cancer.. Journal of the American College of Surgeons. 2014.
  • Nagahashi M., Yamada A., Aoyagi T., Huang WC, Allegood J., Milstien S., Spiegel S., Takabe K. Sphingosine-1-phosphate Signaling Exacerbates Obesity-related Breast Cancer Progression.. Annals of Surgical Oncology. 2014; 21(1).
  • Aoyagi T., Yamada A., Nagahashi M., Huang WC., Terracina KP., Avni D., Milstien S., Spiegel S., Takabe K. FTY720, a Sphingosine-1-phosphate Signaling Modulater, as a Novel Therapy for Colon Cancer Peritoneal Carcinomatosis.. Annals of Surgical Oncology. 2014; 21(1).
  • Yamada A., Nagahashi M., Aoyagi T., Huang W., Kida K., Milstien S., S;iegel S., Ishikawa T., Endo I,, Takabe K. Co-Expression of Activated Sphingosine Kinase 1 and ATP-Binding Cassette Transporter C1 (ABCC!) in Breast Cancer is Associated with Significantly Shorter Disease Free Survival.. Journal of Surgical Research. 2014.
  • Nagahashi M., Yamada A., Aoyagi T., Huang W., Allegood J., Milstien S., Spiegel S., Takabe K. Targeting the Sphingosine-1-phosphate Signaling with FTY720 in Obesity Related Breast Cancer Progression.. Journal of Surgical Research. 2014.
  • Aoyagi T., Yamada A., Nagahashi M., Huang W., Terracina KP., Milstien S., Spiegel S., Takabe K. Sphingosine-1-phosphate Receptor Modulator, FTY720, Synergizes with 5-fluorouracil and Prolongs Survival in a CT26 Syngeneic Murine Colon Cancer Carcinomatosis Model.. Journal of Surgical Research. 2014.
  • Aoyagi T., Avni D., Yamada A., Nagahashi M., Huang W., Terracina KP., Milstien S., Spiegel S., Takabe K. Tumor Associated Macrophages and TNF-Alpha Production in CT26 Syngeneic Murine Colon Cancer Peritoneal Carcinomatosis can be Suppressed by Inhibition of Sphingosine-1- Phosphate Signaling.. Journal of Surgical Research. 2014.
  • Aoyagi T., Yamada A., Nagahashi M., Huang W., Terracina KP., Milstien S., Spiegel S., Takabe K. Targeting Sphingosine-1-Phosphate Signaling with FTY720 Suppresses Colon Cancer Peritoneal Carcinomatosis Progression in Both CT26 Syngeneic and HCT116 Xenograft Models.. Journal of Surgical Research. 2014.
  • Terracins KP., Adams BJ., Rashid OM., Yamada A., Nagahashi M., Ramachandran S., Milstien S., Spiegel S., Takabe K. Effect of Sphingosine-1-Phosphate Signaling Disruption in a Murine Synergenic Metastatic Breast Cancer Model.. Journal of Surgical Research. 2014.
  • Nagahashi M., Yamada A., Aoyagi T., Huang WC., Allegood JC., Milstien S., Spiegel S., Takabe K. Does the lipid mediator sphingosine-1-phosphate have a role in obesity-related cancer progression?. Cancer Research. 2013.
  • Takabe K. Expression of ATP-binding cassette transporter C1 (ABCC1) and activated sphingosine kinase 1 in breast cancer are associated with significantly shorter disease free survival.. Cancer Research. 2013.
  • Nagahashi M., Liang J., Kim EY., Harikumar KB., Yamada A., Huang WC., Hait NC., Allegood JC., Price M., Avni D., Takabe K, Kordula T., Milstien S., Spiegel S.. Abstract LB-325: Sphingosine-1-Phosphate Links Chronic Intestinal Inflammation to Development of Colitis-Associated Cancer.. Cancer Research. 2013.
  • Nagahashi M., Kim EY., Yamada A., Ramachandran S., Allegood JC., Hait N., Maceyka M., Milstien S., Spiegel S., Takabe K. Abstract 5000: Spinster 2 exports S1P, an important player in lymph node metastasis”. Cancer Research. 2013.
  • Yamada A., Liang J., Nagahashi M., Kim EY., Harikumar KB., Huang WC., Hait NC., Allegood JC., Avni D., Kordula T., Milstien S., Takabe K, Spiegel S.. Abstract 4887: FTY720 prevent tumorigenesis and suppress the progression of colitis-associated cancer. Cancer Research. 2013.
  • Aoyagi T., Yamada A., Nagahashi M., Milstien S., Spiegel S., Takabe K. The sphingosine-1-phosphate receptor modulator FTY720 synergistically inhibits colon cancer cell growth with 5-fluorouracil, irinotecan and oxaliplatin.. Cancer Research. 2013.
  • Nagahashi M., Kim EY., Yamada A., Ramachandran S., Allegood J., Hait NC., Maceyka M., Milstien S., Spiegel S., Takabe K. The Sphingolipid Transporter Spns2 Maintains Levels of Sphingosine-1-Phosphate in the Lymphatic System and Regulates Lymphatic Vessel Networks.. Annals of Surgical Oncology. 2013.
  • Aoyagi T., Yamada A., Nagahashi M., Milstien S., Spiegel S., Takabe K. The Sphingosine-1-phosphate Receptor Modulator, FTY720, Synergizes with 5-FU and Irinotecan in Colon Cancer Cell Killing. Annals of Surgical Oncology. 2013.
  • Yamada A., Ishikawa T., Ota I., Kimura M., Shimizu D., Tanabe M., Aoyagi T., Nagahashi M., Chishima T., Sasaki T., Ichikawa Y., Takabe K, Endo I.. The Impact of High Expression of an ATP-binding Casette Transporter, ABCC11, in Breast Cancer Subtypes and Survival.. Annals of Surgical Oncology. 2013.
  • Rashid OM., Nagahashi M., Ramachandran S., Dumur C., Schaum J., Milstien S., Spiegel S., Takabe K. Appropriateness of Models of Cancer Cell Implantation to Study Breast Cancer Lung Metastasis Evaluated by Genome-Wide Microarray Analysis.. Journal of Surgical Research. 2013.
  • Nagahashi M., Allegood J., Yamada A., Aoyagi T., Huang W., Miyazaki H., Milstien S., Spiegel S., Takabe K. Development of a New Method to Measure Sphingosine-1-phosphate in Tumor Interstitial Fluid by Liquid Chromatography-Electrospray Ionization Tandem Mass Spectrometry.. Journal of Surgical Research. 2013.
  • Yamada A., Ishikawa T., Ota I., Kimura M., Shimizu D., Tanabe M., Aoyagi T., Nagahashi M., Chishima T., Sasaki T., Ichikawa Y., Takabe K, Endo I.. ATP-binding Cassette Transporter ABCC11 is Highly Expressed in Aggressive Breast Cancer Subtypes and Related With Worse Disease-free Survival.. Journal of Surgical Research. 2013.
  • Aoyagi T., Yamada A., Nagahashi M., Adams BJ, Milstien S., Spiegel S., Takabe K. The Sphingosine-1-phosphate Receptor Modulator, FTY720, Synergizes With 5-FU to Inhibit Growth of Human Colon Cancer Cells.. Journal of Surgical Research. 2013.
  • Takabe K. Development of FTY720 as a Novel Treatment That Targets Obesity-Associated Breast Cancer.. Journal of Women's Health. 2012.
  • Wang Y., Nagahashi M., Takabe K, Gurley EC., Hylemon P., Pandak WM., Zhang L., Zhou H.. Tu1820 Sphingosine Kinase 2 Deficiency Disrupts Hepatic Lipid Metabolism.. Gastroenterology. 2012.
  • Takabe K. Evaluation of cancer cell implantation method to generate murine metastatic breast cancer model for translational research and drug development.. Journal of Women’s Health. 2012.
  • Nagahashi M., Ramachandran S., Kim EY., Allegood JC., Rashid OM., Yamada A., Zhao R., Milstien S., Zhou H., Spiegel S., Takabe K. Abstract 4364: S1P generated by SphK1 is important not only for primary tumor growth but also for tumor-induced hemangiogenesis and lymphangiogenesis.. Cancer Research. 2012.
  • Yamada A., Nagahashi M., Ramachandran S., Kim EY., Allegood JC., Rashid OM., Milstien S., Spiegel S., Takabe K. Abstract 5280: Activation of sphingosine kinase 1 is necessary for angiopoietin 2-induced hemangiogenesis and lymphangiogenesis.. Cancer Research. 2012.
  • Adams BJ, Nagahashi M., Ramachandran S., Hait NC., Milstien S., Spiegel S., Takabe K. The Preclinical Development of FTY720, a Sphingosine-1-Phosphate Receptor Modulator, as a Novel Targeting Therapy against Breast Cancer.. Journal of Surgical Research. 2012.
  • Rashid OM., Nagahashi M., Ramachandran S., Graham L., Bear HD., Takabe K. Primary Tumor Resection Decreased the Number of Myeloid Derived Suppressor Cells and Increased CD4 and CD8 Cells.. Journal of Surgical Research. 2012.
  • Adams BJ., Nagahashi M., Ramachandran S., Hait N., Milstien S., Spiegel S., Takabe K. Targeting Breast Cancer Metastasis Using FTY720.. Journal of Surgical Research. 2012.
  • Rashid OM., Nagahashi M., Ramachandran S., Takabe K. Surgical Stress and Removal of Primary Lesion Influence Breast Cancer Progression, but Survival is Determined by Overall Tumor Burden.. Journal of Surgical Research. 2012.
  • Rashid OM., Nagahashi M., Dumur C., Ramachandran S., Takabe K. Genome-wide Microarray Analysis Demonstrates Significantly Different Tumor Gene Expression Profiles between Sites of 4T1 Cell Implantation.. Journal of Surgical Research. 2012.
  • Nagahashi M., Ramachandran S., Kim EY., Allegood JC., Rashid OM., Milstien S., Spiegel S., Takabe K. Specific inhibitor of sphingosine kinase 1 suppresses tumor-induced angiogenesis and lymphangiogenesis.. Journal of the American College of Surgeons. 2011.
  • Takabe K, Nagahashi M., Ramachandran S., Kim EY., Rashid OM., Milstien S., Spiegel S.. Sphingosine-1-phosphate Axis as a Novel Target for Metastatic Breast Cancer by Suppression of Angiogenesis and Lymphangiogenesis.. Journal of Women’s Health. 2011.
  • Nagahashi M., Rashid OM., Ramachandran S., Milstien S., Spiegel S., Takabe K. Effect of sphingosine kinase 1 inhibition in validated syngeneic mouse breast cancer metastasis model.. Cancer Research. 2011.
  • Rashid OM., Nagahashi M., Ramachandran S., Takabe K. Choosing The Right Translational Animal Model Matters: Subcutaneous Versus Orthotopic Implantation of Mouse Breast Cancer Differentially Expresses Genes Important For Cancer Research And Drug Development.. Journal of Surgical Research. 2011.
  • Nagahashi M., Ramachandran S., Rashid OM., Milstien S., Spiegel S., Takabe K. Targeting sphingosine kinase 1 is promising novel strategy against breast cancer.. Cancer Research. 2011.
  • Ramachandran S., Shida D., Nagahashi M., Ramachandran S., Milstien S., Takabe K. Abstract 4103: Sphingosine kinase-1 mediates LPA-induced gastric cancer cell proliferation.. Cancer Research. 2011.
  • Rashid OM., Nagahashi M., Ramachandran S., Milstien S., Spiegel S., Takabe K. Abstract 475: Resection of primary tumor improves survival in mouse metastatic breast cancer model.. Cancer Research. 2011.
  • Takabe K. Are We Using the Appropriate Mouse Model to Study Breast Cancer Progression. Journal of Women's Health. 2010.
  • Nagahashi M., Ramachandran S., Rashid OM., Milstien S., Spiegel S., Takabe K. Sphingosine Kinase 1: A New Target Against Breast Cancer.. Annals of Surgical Oncology. 2010.
  • Rashid OM., Kim RH., Allegood JC., Ramachandran S., Nagahashi M., Spiegel S., Takabe K. Non-Genomic ER-Alpha but Not GPR30 Is Involved in Estradiol-Mediated Release of Sphingosine-1-Phosphate from Breast Cancer.. Journal of Surgical Research. 2010.
  • Nagahashi M., Kim RH., Allegood JC., Ramachandran S., Spiegel S., Takabe K. Estradiol-Induced Sphingosine-1-Phosphate Is Released via ABCC1 and ABCG2, and Activates ERK1/2.. Journal of Surgical Research. 2010.
  • Takabe K, Allegood JC., Kim RH., Mitra P., Ramachandran S., Nagahashi M., Harikumar KB., Hait NC., Milstien S., Spiegel S.. Estradiol-Mediated Export of Sphingosine 1-Phosphate from Breast Cancer Cell Is Via Non-Genomic Effect of Estrogen Receptor and Not GPR30.. Journal of Women’s Health. 2009.
  • Kim RH., Takabe K, Allegood JC., Mitra P., Spiegel S.. Estradiol, but not Epidermal Growth Factor, stimulates rapid production and export of sphingosine 1-phosphate from human breast cancer cells.. Annals of Surgical Oncology. 2009.
  • Takabe K, Mitra P., Spiegel S.. The role of ABC transporter in export of sphingosine 1-phosphate from breast cancer cell.. Journal of Women’s Health. 2008.
  • Takabe K, Mitra P., Spiegel S.. ABC transporters, ABCC1 and ABCG2, are involved in estradiol-induced export of sphingosine 1-phospate from human breast cancer cells. AACR Annual. AACR Annual Meeting 2008 Proceedings. 2008.
  • Tomiya T., Takabe K, Inoue Y., Tejima K., Ikeda H., Nishikawa T., Watanable N., Ohtomo N., Omata M., Vale W., Fujiwara K.. Serum follistatin levels as a marker of hepato-gastrointestinal carcinomas.. Journal of Gastroenterology and Hepatology. 2007.
  • Takabe K, Tomiya T., Vale W.. Serum Follistatin Levels Immediately after Hepatectomy Predict the Extent of Liver Regeneration.. Annals of Surgical Oncology. 2007.
  • Yen TY., Kalmaz D., Takabe K, Acosta JA., Hunt GC.. Massive lower gastrointestinal bleeding in a patient newly diagnosed with human immunodeficiency virus.. American Journal of Gastroenterology. 2006.
  • Takabe K. Hernia Sac Laparoscopy under Spinal Anesthesia for Evaluation of Reduced Incarcerated Inguinal Hernia.. Surgical Endoscopy and Other Interventional Techniques. 2006.
  • Takabe K, Tomiya T., Vale W.. Serum Follistatin Levels Predict the Extent of Liver Regeneration after Hepatectomy in Human and Rat Models.. Journal of the American College of Surgeons. 2004.
  • Takabe K, Vale W.. Activin inhibits liver regeneration from overgrowing.. Journal of the American College of Surgeons. 2003.
  • Tomiya T., Takabe K, Inoue Y., Tejima K., Yanase M., Arai M., Ikeda H., Vale W., Fujiwara K.. Serum Follistatin Level Predict Liver Regeneration in Hepatectomized Patients.. Hepatology. 2002.
  • Takabe K, Shintani Y., Kubota T., Shimada H., Vale W.. Serum Follistatin Level as an Early Detection Marker of Post-hepatectomy Liver Failure: Using Our Novel Rat 90 Hepatectomy Model.. Gastroenterology. 2001.
  • Takabe K, Shintani Y., Kubota T., Shimada H., Vale W.. Effects of Massive Liver Removal on Serum Follistatin Levels.. Program. 2001.
  • Takabe K, Wang L., MacConell LA., Leal AM., Wiater E., Bilezikjian LM., Verma IM., Vale W.. Adenovirus-mediated Overexpression of Follistatin Results in Enlargement of the Liver in Normal Adult Rats.. Hepatology. 2000.
  • Takabe K, Wang L., Donaldson CJ., Wiater EM., Bilezikjian LM., Verma IM., Vale W.. Adenovirus-mediated Overexpression of Follistatin Enlarge the Intact Liver in Rats.. Program. 2000.
  • Takabe K, Wang L., Wiater E., Bilezikjian LM., Verma IM., Vale W.. Recombinant Adenovirus Vector Encoding Follistatin: A Potential Tool to Stimulate Liver Regeneration.. Hepatology. 1999.
  • Takabe K, Lebrun JJ., Ichikawa Y., Endo I., Fujii Y., Togo S., Shimada H.. Expression of Activin in Hepatoma Cell Lines and Its Signal Transduction.. The Japanese Journal of Gastroenterological Surgery. 1999.
  • Takabe K, Ichikawa Y., Shimada H.. Cell Growth Effect Using Activin A Antisense Oligonucleotide – Future Drug for Liver Regeneration.. Nippon Geka Gakkai Zasshi (Journal of Japan Surgical Society). 1998.
  • Takabe K, Lebrun JJ., Ichikawa Y., Vaughn J., Mitsuhashi M., Nagashima Y., Shimada H., Vale W.. Use of an Antisense Oligonucleotide Approach to Assess the Role of Activin as an Anti-proliferative agent in the Liver.. Program. 1998.
  • Lebrun JJ., Takabe K, Chen Y., Vale W.. Ligand-dependent Association of Smad2 and Smad3 with the Activin Receptor Complex.. Program. 1998.
  • Takabe K, Ohki S., Sakashita T., Kunihiro O., Ichikawa Y., Togo S., Endo I., Shimada H.. A Case of Intestinal Anisakis that Caused Strangulating Intestinal Obstruction.. Journal of Kanagawa Medical Society. 1998.
  • Takabe K, Ichikawa Y., Nagashima Y., Kubota T., Ishikawa T., Momiyama N., Sekido H., Togo S., Nakano A., Shimada H.. Activin A Expression and Suppression During Liver Regeneration – Findings using Activin A Antisense Oligo.. Acta Hepatologica Japonica. 1997.
  • Takabe K, Ichikawa Y., Nagashima Y., Kubota T., Ishikawa T., Momiyama N., Sekido H., Togo S., Nakano A., Shimada H.. Activin A and its Antisense Oligonucleotide – As a Marker of Liver Regeneration and as an Accelerator.. Nippon Geka Gakkai Zasshi (Journal of Japan Surgical Society). 1997.
  • Takabe K, Ichikawa Y., Nagashima Y., Kubota T., Ishikawa T., Momiyama N., Sekido H., Togo S., Nakano A., Shimada H.. Expression of Activin A mRNA After Hepatectomy – Can it be a Marker of Liver Regeneration?. The Japanese Journal of Gastroenterological Surgery. 1997.
  • Takabe K, Ichikawa Y., Nagashima Y., Ishikawa T., Momiyama N., Eto Y., Mitsuhashi M., Shimada H.. Activin A Antisense Oligodeoxynucleotides Accelerate Hepatic Cell Proliferation.. Gastroenterology. 1997.
  • Takabe K, Nakano A., Shimada H.. Mechanism of Worsening of Postoperative Sepsis and Its Treatment.. Journal of United Surgical Association of Japan. 1996.
  • Takabe K, Tetsuya Ohtani T., Ichiro Muto I., Yukio Takano Y.. Outcome of the Treatments of Thyroid Cancer Recurrence.. Journal of Niigata Medical Society. 1996.
  • Takabe K, Ichikawa Y., Ishikawa T., Momiyama N., Nagashima Y., Shimada H.. Quantitative Detection of Activin A mRNA in The Liver by Competitive PCR.. Hepatology. 1996.
See all (81 more)

Professional Memberships:
  • Southern Surgical Association (2014–present)
  • Society of University Surgeons (2014–present)
  • Surgical Biology Club (2013–present)
  • Richmond Academy of Medicine (2013–present)
  • American Society of Breast Surgeons (2010–present)
  • American Society of Breast Disease (2009–present)
  • American Association for the Advancement of Science (2008–present)
  • Association for Academic Surgery (2008–present)
  • Medical Society of Virginia (2008–present)
  • Massey Cancer Center Cancer Cell Signaling group member (2008–present)
  • Society of Surgical Oncology (2007–present)
  • American Society of Clinical Oncology (2007–present)
  • Japanese Medical Society of America (2007–present)
  • American Association for Cancer Research (2007–present)
  • American Medical Association (2006–present)
  • The Society of American Gastrointestinal and Endoscopic Surgeons (2005–present)
  • American College of Surgeons (2003–present)
  • American Hepato-Pancreato-Biliary Association (2003–present)
  • The American Board of Hospital Physicians (2003–present)
  • The Endocrine Society (1999–present)
  • International Liver Transplantation Society (1998–present)
  • International Association of Surgeons, Gastroenterologists and Oncologists (1998–present)
  • Japan Surgical Society (1993–present)
  • Japan Gastrointestinal Surgery Society (1993–present)
  • The Japanese Society of Gastroenterology (1993–present)
See all (15 more)
Presentations:
  • "“852299: Murine radical mastectomy model for preclinical study of adjuvant systemic therapies”" 2016 San Antonio Breast Cancer Symposium (2016)
  • "“852300: Combination of Doxorubicin with S1P signaling modulator FTY720 significantly suppressed obesity associated breast cancer”" 2016 San Antonio Breast Cancer Symposium (2016)
  • "Breast Cancer Care and Research at Roswell Park Cancer Institute" Learning Academy at Amberleigh Retirement Community (2016)
  • "Challenges of a Breast Surgery Chair at Roswell Park Cancer Institute" Yokohama City University Reception (2016)
  • "How to make a surgeon American way" Tokyo Medical University Medical Student Lecture (2016)
  • "Precision Medicine and Our Challenges" Denka Invited Lecture (2016)
  • "Research Topics that a Surgical Trainee can Accomplish" RPCI Surgical Oncology Grand Rounds (2016)
  • "Role of S1P in cancer progression and microenvironment" Yokohama City University Graduate School Seminar (2016)
  • "Success is not to keep up, but to get up as many as falling" Niigata University project for promotion of global human resource development Medical Student Lecture (2016)
  • "Update on Genomic Medicine in the US" Yakult Meeting (2016)
  • "What can be achieved as a Chief of Breast Surgery at Roswell Park Cancer Institute" Memorial Lecture (2016)
  • "What is research by surgeons" Tsumura Meeting at Yujin Memorial Hall, Niigata Unviersity (2016)
  • "Vision of Roswell Park Cancer Institute Breast Surgery Division" Buffalo Sabres Alumini Luncheon (RPCI) (2016)
  • "“Murine Radical Mastectomy Model for the Drug Development of Adjuvant Therapies”" Post Doc Symposium (RPCI) (2016)
  • "“Novel Subclassification using MicroRNA Expression Patterns of Breast Cancer with Significant Clinical Relevance” K" Post Doc Symposium (2016)
  • "Murine Models that Mimic Human Cancer Progression and Rose of Sphingosine-1-phosphate (S1P) in cancer progression" RPCI Experimental Therapeutics Program Retreat (RPCI) (2016)
  • "Appropriate mice models to address this question - A surgeon's perspective-" RPCI Retreat (2016)
  • "Closing Remark of the fourth US-Japan Clinical Trials in Oncology Workshop" Fourth US-Japan Clinical Trials in Oncology Workshop, Japan Society (2016)
  • "“Current Practice of Precision Medicine in the US”" Next Generation Sequencing Diagnostics for Optimal Treatment, Japan Meeting at ASCO 2016 (2016)
  • "Remaris" Welcome Reception (RPCI) (2016)
  • "“Conjugated bile acids aggravate metastatic pancreatic cancer via sphingosine1phosphate receptor 2”" The 107th Annual Meeting American Association of Cancer Research (2016)
  • "“Newer platinum agent, Triplatin NC, is as effective as Triplatin for metastatic breast cancer and pancreatic cancer carcinomatosis”" The 107th Annual Meeting American Association of Cancer Research (2016)
  • "“How Fast Can the Immune Response Eliminate Murine Cancer Cells from a Different Background?”" Society of Surgical Oncology's 69th Annual Cancer Symposium (2016)
  • "“How to survive as a Physician/Scientist”" National Health Institute Kinyokai (2016)
  • "“P401: Conjugated Bile Acid Promote the Proliferation of Pancreatic Cancer via Sphingosine 1-Phosphate Receptor 2”" Society of Surgical Oncology's 69th Annual Cancer Symposium (2016)
  • "“P405: Inflammation Induced by Sphingosine Kinase of the Host Aggravates Pancreatic Cancer Peritoneal Carcinomatosis”" Society of Surgical Oncology's 69th Annual Cancer Symposium (2016)
  • "“Sphingosine-1-phosphate Signaling Targeted by FTY720 Suppress Obesity-related Breast Cancer Progression, Metastasis, and Improve Survival”" Society of Surgical Oncology Annual Meeting 2016 (2016)
  • "“Are Animal Models Useful For Training a Preclinical Medical Student?”" 11th Annual Academic Surgical Congress (2016)
  • "“Establishment of a Novel Murine Model of Obstructive Jaundice”" 11th Annual Academic Surgical Congress (2016)
  • "“Expression of VEGFA and VEGFR correlates with Disease Free and Overall Survival in Colorectal Cancer”" 11th Annual Academic Surgical Congress (2016)
  • "“Factors and Methods to Improve the Success Rate of Intravenous Catheterization by Medical Students” Woelfel" 11th Annual Academic Surgical Congress (2016)
  • "“Gene expression of Angiopoietin, Tie and VEGF are associated with poor survival in breast cancer”" 11th Annual Academic Surgical Congress (2016)
  • "“Murine Breast cancer cells eliminated in non-derived strain mice; using an improved breast cancer model”" 11th Annual Academic Surgical Congress (2016)
  • "“Obstructive Jaundice Aggravate Pancreatic Cancer via Sphingosine 1 Phosphate Receptors”" 11th Annual Academic Surgical Congress (2016)
  • "“Platinum Agents, Triplatin and TriplatinNC, Suppress 4T1 Murine Breast Cancer Lung Metastasis”" 11th Annual Academic Surgical Congress (2016)
  • "“Role of Sphingosine-1-phoshate of the Host in Progression of Pancreatic Cancer Carcinomatosis”" 11th Annual Academic Surgical Congress (2016)
  • "Image-based Density/Elasticity Guided Biopsy to Overcome Cancer Heterogeneity" VCU Surgery - School of Engineering Research Meeting (2015)
  • "“Obesity increases the lipid mediator, sphingosine-1-phosphate in the tumor and tumor microenvironment, and promotes tumor progression”" 2015 San Antonio Breast Cancer Symposium (2015)
  • "“Sphingosine-1-phosphate signaling promotes metastatic niches and lung metastasis in obesity-related breast cancer”" 2015 San Antonio Breast Cancer Symposium (2015)
  • "“Conjugated bile acid aggravate metastatic pancreatic cancer both in vitro and in vivo”" 50th Southeastern Regional Lipid Conference (SERLC 2015) (2015)
  • "“Establishment of a mouse model that mimic human breast cancer progression”" 50th Southeastern Regional Lipid Conference (SERLC 2015) (2015)
  • "“What is wrong being fat?”" 25th Medical Lecture for Japanese Society in Virginia,, The Japan-Virginia Society (2015)
  • "“Angiogenesis Gene Expression and Poor Outcomes in Breast Cancer”" VCU Department of Surgery Research Day (2015)
  • "“Appropriate amount of Matrigel to be inoculated in C57BL/6 mice mammary glands”" 2015 VCU Massey Cancer Center Research Retreat (2015)
  • "“Gene silencing of SphK1 with novel nanoparticles as an innovative approach against cancer progression”" Medical Student Honors Day (2015)
  • "“Role of Sphingosine Kinase 1 of the Host in the Progression of Pancreatic Cancer Peritoneal Carcinomatosis”" 2015 VCU Massey Cancer Center Research Retre (2015)
  • "“Social media is rapidly expanding. How can ASCO employ new communication methods to best serve its members and the larger organization?”" American Society of Clinical Oncology Board Meeting at 2015 ASCO 51st Annual Meeting (2015)
  • "“The use of novel carbonate apatite nanoparticles in 4T1 murine breast cancer cells to down regulate sphingosine kinase 1 and inhibit migration”" 2015 VCU Massey Cancer Center Research Retreat (2015)
  • "Closing Remark of the third US-Japan Clinical Trials in Oncology Workshop" Third US-Japan Clinical Trials in Oncology Workshop (2015)
  • "Role of Sphingosine-1-phosphate (S1P) in Tumor Microenvironment& Cancer Progression" Virginia Commonwealth University, Department of Biology (2015)
  • "“Are the genomic gene expression profiles maintained between the original donor and patient-derived xenograft tumors?”" The 106th Annual Meeting American Association of Cancer Research (2015)
  • "“FTY720 suppressed CT26 murine colon cancer peritoneal carcinomatosis progression by decreasing tumor associated macrophages and TNF-alpha” ”" The 106th Annual Meeting American Association of Cancer Research (2015)
  • "“How a Surgeon/Scientist who does research on role of sphingolipids in cancer survived”" , University of Pennsylvania (2015)
  • "“Obesity increase sphingosine-1-phosphate in tumor microenvironment”" Annual meeting of Japan Surgical Society (2015)
  • "“Surgeon/Scientist on Sphingolipid research - Turning the weakness into strength”" New York Life Science Forum 2015 at New York University, Langone Medical Center, Japanese Medical Society in America (JMSA) (2015)
  • "“Introducing J-RAV (Japanese Researchers’ Association in VCU)”" “Introducing J-RAV (Japanese Researchers’ Association in VCU)”, United Japanese Researchers Association (UJA) (2015)
  • "“Is Patient Derived Xenograft Model Appropriate for Colon Cancer Preclinical Drug Development?”" Annual meeting of Society of Surgical Oncology (2015)
  • "“Modified orthotopic murine colon cancer cell implantation method that mimics clinical cancer progression”" Annual meeting of Society of Surgical Oncology (2015)
  • "“Gene silencing of SphK1 with nanoparticles as an innovative approach against cancer progression”" 10th Annual Academic Surgical Congress (2015)
  • "“Improvements to a Murine Colon Cancer Model for Cancer Progression and the Tumor Microenvironment”" 10th Annual Academic Surgical Congress (2015)
  • "“Role of sphingosine kinase 1 of the host in the progression of pancreatic cancer peritoneal carcinomatosis”" 10th Annual Academic Surgical Congress (2015)
  • "“Role of Sphingosine-1-Phosphate in Inflammation-Induced Lymphangiogenesis”" 10th Annual Academic Surgical Congress (2015)
  • "“S1P Forms a Feed-Forward Loop with the Ang2 and VEGF-C Pathways in Lymphangiogenesis”" 10th Annual Academic Surgical Congress (2015)
  • "Why Surgical Oncology" David Humes Surgical Society lunch lecture (2015)
  • "“Introducing J-RAV (Japanese Researchers’ Association in VCU)”" Joint United Japanese Researchers Association (UJA) and Japanese Society for Promotion of Science (JSPS) Meeting (2014)
  • "“Sphingosine-1-Phosphate Signaling as a Target in Inflammation-promoted Cancer Progression”" 10th Anual Academic Surgical Confrass, Society of Unviersity Surgeons New Member Poster Presentations (2014)
  • "Cancer of the Colon" BIOL-450 Biology of Cancer I, Virginia Commonwealth University Lecture (2014)
  • "Research Environment of American Surgeon/Scientist" Panel Discussion, 76th Annual Meeting of Japan Clinical Surgery Society (2014)
  • "Role of Sphingosine-1-phosphate (S1P) in Tumor Microenvironment and Cancer Progression" Massey Cancer Center Cancer Cell Signaling Program Retreat (2014)
  • "“Closing Remarks by the Conference Chair”" 49th Southeastern Regional Lipid Conference (SERLC 2014) (2014)
  • "“Conjugated Bile Acid Activated S1P Receptor 2 Is a Key Regulator of Sphingosine Kinase 2 and Hepatic Gene Expression”" 49th Southeastern Regional Lipid Conference (SERLC 2014) (2014)
  • "“FTY720 Decrease Sphingosine-1-phosphate in the Tumor Interstitial Fluid Collected by Novel Methods”" 49th Southeastern Regional Lipid Conference (SERLC 2014) (2014)
  • "“Opening Remarks by the Conference Chair”" 49th Southeastern Regional Lipid Conference (SERLC 2014) (2014)
  • "“Patient-Derived Xenograft Murine Model Does Not Reproduce Sphingosine-1-Phosphate Signaling of the Original Patient Colon Cancer”" 49th Southeastern Regional Lipid Conference (SERLC 2014) (2014)
  • "“Primary colon cancer model for analysis of tumor microenvironment and cancer progression”" 49th Southeastern Regional Lipid Conference (SERLC 2014) (2014)
  • "“Sphingosine-1-phosphate produced by sphingosine kinase 1 and exported via ABCC1 shortens breast cancer survival”" 49th Southeastern Regional Lipid Conference (SERLC 2014) (2014)
  • "“Targeting sphingosine-1-phosphate signaling with FTY720 suppresses progression of colon cancer peritoneal carcinomatosis and prolongs survival”" 49th Southeastern Regional Lipid Conference (SERLC 2014) (2014)
  • "“Activated SphK1 and export of S1P via ABCC1 shorten disease free survival in breast cancer”" NIH-Japan-JSPS Symposium: Highlights from the Frontier of Biomedical Science from NIH and Japan, Lipsett Auditorium of NIH (2014)
  • "“FTY720, a sphingosine-1-phosphate receptor modulator, as a novel targeted therapy against colitis-associated cancer”" American College of Surgeons Annual Clinical Congress (2014)
  • "“Role of Sphingosine-1-phosphate (S1P) in cancer progression”" Annual meeting of the Surgical Biology Club (2014)
  • "“Sphingosine-1-phosphate signaling targeted therapy suppresses obesity-related breast cancer progression and improves survival”" American College of Surgeons Annual Clinical Congress (2014)
  • "Obesity and Sphingosine-1-phosphate" Cancer and Metabolism Working Group Meeting (2014)
  • "“At What Age Should We Recommend Screening Mammography for Asian Women?”" VCU Surgical Oncology Conference (2014)
  • "“Role of Sphingosine-1-phosphate (S1P) in tumor microenvironment and cancer progression”" Hollings Cancer Center at Medical University South Carolina. (2014)
  • "Role of Sphingosine-1-phosphate (S1P) in Tumor Microenvironment and Cancer Progression" VCU Surgery Grand Rounds (2014)
  • "“Evaluation of fingolimod as a treatment strategy in metastatic breast cancer”" The 11th Annual VCUHS Resident/Fellow Research Day at VCU (2014)
  • "“Sphingosine-1-phospahte Signaling in Cancer Progression and Cancer Therapy”" VCU Department of Surgery Research Conference (2014)
  • "“SphK1-S1P-S1PR1 axis inhibition results in anti-tumor effects in a murine model of colon cancer peritoneal carcinomatosis”" The 11th Annual VCUHS Resident/Fellow Research Day at VCU (2014)
  • "“Advanced murine models of colon cancer progression and metastasis”" VCU Department of Surgery Research Day (2014)
  • "“An improved syngeneic colon cancer model for studies in cancer progression and metastasis”" 2014 VCU Massey Cancer Center Research Retreat (2014)
  • "“Development of a syngeneic orthotopic murine colon cancer model for preclinical studies targeting the tumor microenvironment”" Virginia Surgical Society (2014)
  • "“FTY720 suppress colon cancer peritoneal carcinomatosis progression by targeting sphingosine-1-phosphate signaling and suppressing tumor-associated macrophages”" 2014 VCU Massey Cancer Center Research Retreat (2014)
  • "“New methods for measurement of sphingosine-1-phosphate in tissue interstitial fluid and lymphatic fluid for analysis of tumor microenvirionment”" 2014 VCU Massey Cancer Center Research Retreat (2014)
  • "“Outcomes of hybrid VATS for pulmonary metastasectomy”" VCU Department of Surgery Research Day (2014)
  • "“Overexpression of ABCC1, but not ABCB1, correlates with breast cancer patient survival”" 2014 VCU Massey Cancer Center Research Retreat (2014)
  • "“Preclinical evaluation of FTY720 as a novel therapeutic for colon cancer peritoneal carcinomatosis" Virginia Chapter, American College of Surgeons (2014)
  • "“Preclinical evaluation of FTY720 targeting S1P signaling for colon cancer peritoneal carcinomatosis”" VCU Department of Surgery Research Day (2014)
  • "“Sphingosine-1-phosphate signaling: A novel therapeutic target for obesity-related breast cancer metastasis”" VCU Massey Cancer Center Research Retreat (2014)
  • "“STAT3 interacts with cyclophilin D in cancer cells to regulate the MPTP”" 2014 VCU Massey Cancer Center Research Retreat (2014)
  • "Role of Sphingosine-1-phosphate in inflammation and cancer" Department of Microbiology and Immunology Graduate Student Seminar (2014)
  • "“Activated SphK1 and export of S1P via ABCC1 Shorten Disease Free Survival in Breast Cancer”" The 105th Annual Meeting American Association of Cancer Research (2014)
  • "“Breast cancers that co-express ABCC1 and Sphingosine kinase 1 have poor prognosis”" Annual meeting of Japan Surgical Society (2014)
  • "“Determination of Sphingosine-1-phosphate levels in Tissue Interstitial Fluid and Lymphatic Fluid Utilizing Novel Collection Techniques”" The 105th Annual Meeting American Association of Cancer Research (2014)
  • "“FTY720 as a novel therapeutic approach for colon cancer carcinomatosis”" The 105th Annual Meeting American Association of Cancer Research (2014)
  • "“Sphingosine-1-phosphate in Breast and Colon Cancer”" ASONEP Advisory Panel Meeting. (2014)
  • "“Targeting sphingosine-1-phosphate signaling as a therapeutic strategy for breast cancer lung metastasis”" The 10th Annual VCU Women’s Health Research Day (2014)
  • "American surgeon/scientist-forefront of targeted therapy development" Aiseki Gastrointestinal Surgery Seminar at the Jikei University (2014)
  • "Targeting S1P by FTY720 in obesity-related inflammation and breast cancer metastasis" Breast Cancer Research Interest Group Meeting, Massey Cancer Center (2014)
  • "What it means to work internationally" International Career Symposium, Niigata University Global Workforce Development Program (2014)
  • "“FTY720, a functional antagonist of sphingosine-1-phosphate signaling, as a novel therapy for colon cancer peritoneal carcinomatosis”" 67th Annual Cancer Symposium, the Society of Surgical Oncology (2014)
  • "“Sphingosine-1-phosphate signaling exacerbates obesity-related breast cancer progression”" 67th Annual Cancer Symposium, the Society of Surgical Oncology (2014)
  • "Cancer Epidemiology and Prevention" Junior General Surgery Resident Basic Science Lecture series (2014)
  • "“Co-Expression of Activated Sphingosine Kinase 1 and ATP-Binding Cassette Transporter C1 (ABCC1) in Breast Cancer is Associated with Significantly Shorter Disease Free Survival”" 9th Annual Academic Surgical Congress (2014)
  • "“Sphingosine-1-phosphate Receptor Modulator, FTY720, Synergizes with 5-fluorouracil and Prolongs Survival in a CT26 Syngeneic Murine Colon Cancer Carcinomatosis Model”" 9th Annual Academic Surgical Congress (2014)
  • "“Sphingosine-1-phosphate Receptor Modulator, FTY720, Synergizes with 5-fluorouracil and Prolongs Survival in a CT26 Syngeneic Murine Colon Cancer Carcinomatosis Model”" 9th Annual Academic Surgical Congress (2014)
  • "“Targeting Sphingosine-1-Phosphate Signaling with FTY720 Suppresses Colon Cancer Peritoneal Carcinomatosis Progression in Both CT26 Syngeneic and HCT116 Xenograft Models”" 9th Annual Academic Surgical Congress (2014)
  • "“Targeting the Sphingosine-1-phosphate Signaling with FTY720 in Obesity Related Breast Cancer Progression”" 9th Annual Academic Surgical Congress (2014)
  • "“Tumor Associated Macrophages and TNF-Alpha Production in CT26 Syngeneic Murine Colon Cancer Peritoneal Carcinomatosis can be Suppressed by Inhibition of Sphingosine-1-Phosphate Signaling”" 9th Annual Academic Surgical Congress (2014)
  • "“Role of Sphingosine-1-phosphate in cancer progression”" National Institute of Health Kinyokai Seminar. (2014)
  • "“Sphingosine-1-phosphate signaling as a novel therapeutic target for obesity related breast cancer metastasis”" 49th Southeastern Regional Lipid Conference (SERLC 2014) (2014)
  • "“ATP-binding cassette transporter C1 (ABCC1) expression in the presence of sphingosine-1-phosphate (S1P) production is associated with significantly shorter disease free survival”" 2013 San Antonio Breast Cancer Symposium (2013)
  • "“Does the lipid mediator Sphingosine-1-phosphate have a role in obesity-related cancer progression?”" 2013 San Antonio Breast Cancer Symposium (2013)
  • "“Role of S1P in obesity-related breast cancer progression" Breast Cancer Research Interest Group Meeting at Massey Cancer Center (2013)
  • "Role of S1P signaling in Cancer" Molecular Pathology Collaborators Meeting (2013)
  • "“Advanced murine orthotopic model systems for the study of lipid signaling in cancer progression”" 48th Annual SouthEastern Regional Lipid Conference (2013)
  • "“Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer”" 48th Annual SouthEastern Regional Lipid Conference (2013)
  • "S1P signaling as a novel target for colon cancer peritoneal carcinomatosis" VCU Surgical Oncology Conference (2013)
  • "What can we do to achieve benchmarks for Massey to become a Comprehensive Cancer Center?" Breast Cancer Research Interest Group Meeting at Massey Cancer Center (2013)
  • "“So you want to be a Doctor”" CODE:13Fall-07 Saturday Enrichment Program for Gifted Learners, The College of William and Mary, Center for Gifted Education (2013)
  • "45 year old man with progressive abdominal swelling'" Department of Internal Medicine Clinicopathologic Conference (2013)
  • "Closing Remark of the second US-Japan Clinical Trials in Oncology Workshop" Second US-Japan Clinical Trials in Oncology Workshop (2013)
  • "Physician/Scientists in the US" Japanese Researchers' Association in VCU (2013)
  • "“Co-expression of sphingosine kinase 1 and ATP-bindign cassette transorter C1 (ABCC1) in human breast cancers correlates with significantly shorter disease free survival”" 2013 VCU Massey Cancer Center Research Retreat (2013)
  • "“SphK1-S1P-S1PR1 axis is essential for persistent activation of STAT3 and connects chronic inflammation and colitis-associated cancer”" 2013 VCU Massey Cancer Center Research Retreat (2013)
  • "“STAT3 interacts with cyclophilin D in cancer cells to regulate the MPTP”" 2013 VCU Massey Cancer Center Research Retreat (2013)
  • "“Targeting sphingosine-1-phosphate signaling with FTY720 inhibits CT26 and HCT116 colon cancer progression in peritoneal carcinomatosis models" 2013 VCU Massey Cancer Center Research Retreat (2013)
  • "“The role of sphingosine-1-phosphate in obesity-related cancer progression”" 2013 VCU Massey Cancer Center Research Retreat (2013)
  • "“FTY720 prevents tumorigenesis and suppresses the progression of colitis-associated cancer”" The 104th Annual Meeting American Association of Cancer Research (2013)
  • "“FTY720, a sphingosine-1-phosphate receptor type 1 (S1PR1) modulator, suppresses obesity-related breast cancer progression in two animal models”" The 9th Annual VCU Women’s Health Research Day (2013)
  • "“Human breast cancers that co-express sphingosine kinase 1 and ABCC1 have significant shorter disease free survival”" The 9th Annual VCU Women’s Health Research Day (2013)
  • "“Sphingosine-1-Phosphate Links Chronic Intestinal Inflammation to Development of Colitis-Associated Cancer”" The 104th Annual Meeting American Association of Cancer Research (2013)
  • "“Spinster 2 exports S1P, an important player in lymph node metastasis”" The 104th Annual Meeting American Association of Cancer Research (2013)
  • "“The sphingosine-1-phosphate receptor modulator, FTY720, synergistically inhibits colon cancer cell growth with 5-fluorouracil, irinotecan and oxaliplatin”" The 104th Annual Meeting American Association of Cancer Research (2013)
  • "Being a surgeon in the US: What lies beyond your dream?" Special Lecture for Medical Students (2013)
  • "Is Surgeon/Scientist necessary? A case of a surgeon who researches the role of Sphingolipids in Cancer Progression" The 8th Meeting of Niigata Cross-sectional Research Group for Digestive Diseases (2013)
  • "Postgraduate surgical training in the US" Special Lecture for Medical Students (2013)
  • "Surgical Research in the US: Is physician/scientist endangered species?" Special Lecture for Surgical Residents and Staffs. (2013)
  • "“The impact of high expression of an ABC transporter, ABCC11, in breast cancer subtypes and survival”" 66th Annual Cancer Symposium, the Society of Surgical Oncology (2013)
  • "“The Sphingolipid Transporter Spns2 Maintains Levels of Sphingosine-1-Phosphate in the Lymphatic System and Regulates Lymphatic Vessel Networks”" 66th Annual Cancer Symposium, The Society of Surgical Oncology (2013)
  • "“The sphingosine-1-phosphate receptor modulator, FTY720, synergizes with 5-FU and irinotecan on colon cancer cell killing”" 66th Annual Cancer Symposium, the Society of Surgical Oncology (2013)
  • "“Appropriateness of Models of Cancer Cell Implantation to Study Breast Cancer Lung Metastasis Evaluated by Genome-Wide Microarray Analysis”" 8th Annual Academic Surgical Congress (2013)
  • "“ATP-binding Cassette Transporter ABCC11 is Highly Expressed in Aggressive Breast Cancer Subtypes and Related With Worse Disease-free Survival”" 8th Annual Academic Surgical Congress (2013)
  • "“Development of a New Method to Measure Sphingosine-1-phosphate in Tumor Interstitial Fuid by Liquid Chromatography-Electrospray Ionization Tandem Mass Spectrometry”" 8th Annual Academic Surgical Congress (2013)
  • "“How to Use This Course to Earn a Grant”" , The Grant Writing Workshop, Association of Academic Surgeons/Society of University Surgeons Surgical Investigators’ Course, (2013)
  • "“The Sphingosine-1-phosphate Receptor Modulator, FTY720, Synergizes With 5-FU to Inhibit Growth of Human Colon Cancer Cells”" 8th Annual Academic Surgical Congress (2013)
  • "New Insights in the Mechanism of Carcinogenesis: An Overview" 22nd World Congress of the Internatioan Association of Surgeons, Gastroenterologists and Oncologists (2012)
  • "Novel mechanism of inflammatory bowel disease related carcinogenesis" 22nd World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists (2012)
  • "Role of sphingolipids on development of non-alcoholic fatty liver disease" 22nd World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists (2012)
  • "The Role of Sphingolipids in Breast Cancer Progression" TokyoBay Urayasu-Ichikawa Medical Center (2012)
  • "“Development of FTY720 as a Novel Treatment That Targets Obesity-Associated Breast Cancer”" Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) Scholars Meeting, National Institute of Health (2012)
  • "“Clinical relevance of the high expression of ABC transporter C11, in the light of breast cancer subtypes”" 2012 VCU Massey Cancer Center Research Retreat (2012)
  • "“Sphingolipids in Tumor Microenvironment Measured by Liquid Chromatography-electrospray Ionization Tandem Mass Spectrometry”" 2012 VCU Massey Cancer Center Research Retreat (2012)
  • "“Sphingosine-1-phosphate secreted by tumors affects their microenvironment and promotes breast cancer progression”" 29th Annual Daniel T. Watts Research Poster Symposium (2012)
  • "“Sphingosine-1-phosphate secreted by tumors affects their microenvironment and promotes breast cancer progression”" 29th Annual Daniel T. Watts Research Poster Symposium (2012)
  • "“The expression of ABC transporter C11 in aggressive breast cancer subtypes is related with poor prognosis”" 29th Annual Daniel T. Watts Research Poster Symposium (2012)
  • "“The S1P Transporter Spinster 2 knockout mice have aberrant lymphatic sinuses”" 2012 VCU Massey Cancer Center Research Retreat (2012)
  • "“The Sphingosine-1-phosphate receptor modulator, FTY720, synergistically inhibit colon cancer cell growth with 5-Fluorouracil and Irinotecan”" 29th Annual Daniel T. Watts Research Poster Symposium (2012)
  • "“The Sphingosine-1-phosphate receptor modulator, FTY720, synergizes with 5-FU and Irinotecan to inhibit growth of colon cancer cells”" 2012 VCU Massey Cancer Center Research Retreat (2012)
  • "Dphinhodinr-1-phosphate Producted by Sphingosine Kinase 1 Promotes Breast Cancer Progression by Stimulating Angiogenesis and Lymphangiogenesis" Journal Club, VCU Department of Internal Medicine (2012)
  • "“Choice of the right translational mouse breast cancer model matters: subcutaneous vs. orthotopic implantation of murine breast cancer differentially express genes important for cancer research and drug development”" Department of Surgery Research Day, VCU (2012)
  • "“Sphingosine kinase 2 deficiency disrupts hepatic lipid metabolism”" Digestive Disease Week 2012 (2012)
  • "“The preclinical development of an S1P receptor type 1 targeting agent”" Department of Surgery Research Day, VCU (2012)
  • "“Activation of sphingosine kinase 1 is necessary for angiopoietin 2-induced hemangiogenesis and lymphangiogenesis”" The 103rd Annual Meeting American Association of Cancer Research (2012)
  • "“ATP-binding transporters, ABCC1 and ABCG2 are expressed higher in triple negative breast cancer”" The 8th Annual VCU Women’s Health Research Day (2012)
  • "“Choice of the Right Translational Mouse Breast Cancer Model Matters: Subcutaneous Versus Orthotopic Implantation of Murine Breast Cancer Differentially Express Genes Important for Cancer Research and Drug Development”" Virginia Chapter, American College of Surgeons (2012)
  • "“How Appropriate a Metastatic Model is Cancer Cell Implantation via Tail Vein Injection to Study Breast Cancer Lung Metastasis? An Evaluation using Genome-wide Microarray Analysis”" Virginia Surgical Society (2012)
  • "“S1P generated by SphK1 is important not only for primary tumor growth but also for tumor-induced hemangiogenesis and lymphangiogenesis”" The 103rd Annual Meeting American Association of Cancer Research (2012)
  • "“Sphingosine kinase 1-induced sphingosine-1-phosphate promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis”" The 8th Annual VCU Women’s Health Research Day (2012)
  • "“Surgical Resection of the Primary Tumor in Metastatic Breast Cancer Decreases Overall Tumor Burden and Improves Survival”" Virginia Surgical Society (2012)
  • "“Development of novel cancer cell implantation method to generate murine metastatic breast cancer model for translational research and drug development”" Women’s Health 2012: The 20th Annual Meeting (2012)
  • "“Genome-wide Microarray Analysis Demonstrates Significantly Different Tumor Gene Expression Profiles between Sites of 4T1 Cell Implantation”" 7th Annual Academic Surgical Congress (2012)
  • "“Primary Tumor Resection Decreased the number of Myleoid Deprived Suppressor Cells and Increased CD4 and CD8 Cells”" 7th Annual Academic Surgical Congress (2012)
  • "“Surgical Stress and Removal of Primary Lesion Influence Breast Cancer Progression, But Survival is determined by Overall Tumor Burden”" 7th Annual Academic Surgical Congress (2012)
  • "“Targeting breast cancer metastasis using FTY720”" 7th Annual Academic Surgical Congress (2012)
  • "“The Preclinical Development of FTY720, a Sphingosine-1-Phosphate Receptor Modulator, as a Novel Targeting Therapy against Breast Cancer”" 7th Annual Academic Surgical Congress (2012)
  • "General Surgery Training in the Untied States" 25th Mito Soushyouchiyu Danwakai" (2012)
  • "Practical Aspects of Postgraduate Education in the United States" Special Lecture at Nippon Medical School (2012)
  • "Obesity in the United States: role of Nutrition Support Team" Annual NST Lecture at Sanraku Hospital (2011)
  • "The role of sphingosine-1-phosphate (S1P) signaling pathway and bile acid in dies induced non-alcoholic fatty liver disease (NAFLD)" 21st World Congress of the International Association of Surgeons, Gastroenterologists and Oncologists." (2011)
  • "“Cancer-induced angiogenesis and lymphangiogenesis are regulated by sphingosine kinase 1”" 2011 VCU Massey Cancer Center Research Retreat (2011)
  • "“Sphingosine-1-phosphate Axis as a Novel Target for Metastatic Breast Cancer by Suppression of Angiogenesis and Lymphangiogenesis”" Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) Scholars Meeting, National Institute of Health (2011)
  • "“Suppression of breast cancer growth and metastatic disease using a novel therapy: FTY720”" 2011 VCU Massey Cancer Center Research Retreat (2011)
  • "“Breast cancer lymph node metastasis is mediated by sphingosine-1-phosphate”" The 7th Annual Integrative cellular and molecular signaling (ICAMS) Research Retreat / Lipid Signaling and Functional Lipidomics in Cardiovascular and Respiratory Diseases (LCRD) Research Retreat (2011)
  • "“Breast cancer subtypes have different expression profiles of ATP-binding cassette transporters”" The 7th Annual Integrative cellular and molecular signaling (ICAMS) Research Retreat / Lipid Signaling and Functional Lipidomics in Cardiovascular and Respiratory Diseases (LCRD) Research Retreat (2011)
  • "“Development of in vivo quantification of angiogenesis and lymphangiogenesis”" 28th Annual Daniel T. Watts Research Poster Symposium (2011)
  • "“Efficacy of FTY720 in the suppression of breast cancer and its lung metastasis”" The 7th Annual Integrative cellular and molecular signaling (ICAMS) Research Retreat / Lipid Signaling and Functional Lipidomics in Cardiovascular and Respiratory Diseases (LCRD) Research Retreat (2011)
  • "“Expressions of ATP-binding cassette transporters varies among subtypes in breast cancer”" 28th Annual Daniel T. Watts Research Poster Symposium (2011)
  • "“FTY720 suppressed breast cancer lung metastasis using a 4T1-luc2 cell implantation model”" 28th Annual Daniel T. Watts Research Poster Symposium (2011)
  • "“Specific inhibitor of Sphingosine Kinase 1 suppresses tumor-induced angiogenesis and lymphangiogenesis”" The 97th Annual American College of Surgeons Clinical Congress (2011)
  • "“Triple negative breast cancer has high expressions of ATP-binding transporters, C1 and G2”" 2011 VCU Massey Cancer Center Research Retreat (2011)
  • "“FTY720 as a novel therapy against breast cancer progression by modulation of the Sphingosine-1-Phosphate receptor”" The 8th Annual VCUHS Resident Research Day at VCU (2011)
  • "“Sphingosine Kinase 1 generated Sphingosine-1-phosphate promotes breast cancer progression by tumor-induced angiogenesis and lymphangiogenesis”" Breast Cancer Research Interest Group Meeting at VCU (2011)
  • "“FTY720 as a novel Sphingosine-1-Phosphate receptor targeting therapy against breast cancer progression”" Department of Surgery Research Day, VCU (2011)
  • "“Genome‐wide Microarray Analysis Validates the Benefits of Orthotopic Breast Cancer Mouse Models for Translational Research in the Era of Targeted Therapy”" 2011 Annual Meeting of Virginia Surgical Society (2011)
  • "“Surgical Resection of the Primary Tumor in Metastatic Breast Cancer Decreases Overall Tumor Burden and Improves Survival”" Department of Surgery Research Day, VCU (2011)
  • "“Effect of sphingosine kinase 1 inhibition in validated syngeneic mouse breast cancer metastasis model”" The 102nd Annual Meeting American Association of Cancer Research (2011)
  • "“S1P produced by SphK1 is an important factor in breast cancer-induced angiogenesis/lymphangiogenesis”" The 7th Annual VCU Women’s Health Research Day (2011)
  • "“Surgical Resection of Primary Tumor in Metastatic Breast Cancer Reduces Overall Tumor Burden and Improves Survival”" The 7th Annual VCU Women’s Health Research Day (2011)
  • "“The Role of Sphingosine-1-phosphate (S1P) in Breast Cancer Progression and lymphangiogenesis" Breast Cancer Research Interest Group Meeting at Virginia Commonwealth University (2011)
  • "“Serum Sphingosine -1-Phosphate Level in Breast Cancer Mouse Model and Patients”" 64th Annual Cancer Symposium,, The Society of Surgical Oncology (2011)
  • "“Choosing The Right Translational Animal Model Matters: Subcutaneous Versus Orthotopic Implantation Of Mouse Breast Cancer Differentially Expresses Genes”" 6th Annual Academic Surgical Congress (2011)
  • "Role of Sphingosine-1-phosphate in cancer progression" Cell Signaling Retreat, VCU Massey Cancer Center Cancer (2010)
  • "“Are We Using the Appropriate Mouse Model to Study Breast Cancer Progression?”" 7th Annual Interdisciplinary Women’s Health Research Symposium (2010)
  • "“Elucidating the role of sphingosine kinase 1 in breast cancer progression using newly validated syngeneic mouse model”" The 45th Annual Southeastern Regional Lipid Conference (2010)
  • "“FTY720 Targeting metastatic breast cancer”" Massey Cancer Center 2010 Cancer Research Retreat (2010)
  • "“Isozyme-specific inhibitor of sphingosine kinase 1 inhibits breast cancer progression and tumor lymphangiogenesis”" Massey Cancer Center 2010 Cancer Research Retreat (2010)
  • "“Lysophosphatidic acid stimulates gastric cancer cell proliferation via ERK1-dependent upregulation of sphingosine kinase 1 transcription”" Massey Cancer Center 2010 Cancer Research Retreat (2010)
  • "“Lysophosphatidic acid stimulates gastric cancer cell proliferation via ERK1-dependent upregulation of sphingosine kinase 1 transcription”" 27th Annual Daniel T. Watts Research Poster Symposium (2010)
  • "“Lysophosphatidic acid stimulates gastric cancer cell proliferation via ERK1-dependent upregulation of sphingosine kinase 1 transcription”" The 6th Annual Integrative cellular and molecular signaling (ICAMS) Research Retreat / Lipid Signaling and Functional Lipidomics in Cardiovascular and Respiratory Diseases (LCRD) Research Retreat (2010)
  • "“Role of Sphingosine-1-phosphate and Sphingosine kinase 1 in Cancer progression and cancer-induced lymphangiogenesis”" 27th Annual Daniel T. Watts Research Poster Symposium (2010)
  • "“Serum S1P levels in breast cancer mouse model and patients”" Massey Cancer Center 2010 Cancer Research Retreat (2010)
  • "“Sphingosine-1-phosphate induces lymphangiogenesis in syngeneic mouse breast cancer model”" The 6th Annual Integrative cellular and molecular signaling (ICAMS) Research Retreat / Lipid Signaling and Functional Lipidomics in Cardiovascular and Respiratory Diseases (LCRD) Research Retreat (2010)
  • "“Why obesity is unhealthy”" 16th Medical Lecture for Japanese Society in Virginia, The Japan-Virginia Society (2010)
  • "Sphingosine-1-phosphate in breast cancer and associate lymphangiogenesis" VCU BIRCWH Scholar meeting (2010)
  • "“Mouse breast cancer model demonstrates survival benefit of mastectomy in metastatic breast cancer”" The 7th Annual VCUHS Resident Research Day at Virginia Commonwealth University (2010)
  • "Sphingosine Kinase 1 as a New Target to Treat Breast Cancer" The 6th Annual Women's Health Research Day at Virginia Commonwealth University (2010)
  • "Esophageal Cancer and Pancreatic Cancer" Q and A Session for Junior Surgical Residents in VCU program (2010)
  • "How to Prevent Common Cold" Lecture in Japanese for Richmond Branch of Japanese School (2010)
  • "Overview of the Link between SphK2/S1P2 and Liver" Sphingosine-1-phosphate, Liver and Bile Acids (Morning workshop) (2010)
  • "Overview of the Link between SphK2/S1P2 and Liver" Liver and Bile Acids (2010)
  • "The Role of Sphingosine-1-phosphate (S1P) in Breast Cancer Progression and Drug Resistance" Breast Cancer Research Interest Group Meeting, Virginia Commonwealth University (2010)
  • "New Frontiers in the Management of Colorectal Cancer Liver Metastasis" 17th International Postgraduate Course, International Association of Surgeons, Gastroenterologists and Oncologists. (2009)
  • "“Estradiol-mediated export of sphingosine 1-phosphate from breast cancer cell is via non-genomic effect of estrogen receptor, and not GPR30”" Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) Scholars Meeting, National Institute of Health (2009)
  • "Systemic Therapy of Colon Cancer" 19th Worlld Congress of the International Association of Surgeons, Gastroenterologists and Oncologists (2009)
  • "“Discovering How Research Helps Fight Breast Cancer”" Discovery Dialogues Seminar at Virginia Commonwealth University (2009)
  • "The Reality of American Medical Practice" , Yokohama City University Graduate School of Medicine, Dean‘s Invited Lecture for Graduate Students (2009)
  • "“Estradiol stimulates export of sphingosine-1-phosphate from breast cancer cells by specific ABC transporters”" The 100th Annual Meeting of American Association of Cancer Research (2009)
  • "“Rapid export of sphingosine-1-phosphate from breast cancer cells MCF-7 is mediated by estradiol and ABCC1 transporter”" Experimental Biology 2009, American Society for Biochemistry and Molecular Biology (2009)
  • "“Estradiol (E2) Induces Immediate Export of Sphingosine 1-phosphate (S1P) from Breast Cancer Cells by Specific ATP-Binding Cassette (ABC) Transporters”" Breast Cancer Research Interest Group Meeting at Virginia Commonwealth University (2009)
  • "“What is Coming Next on Treatment of Colon Cancer Liver Metastasis”" 16th International Postgraduate Course & 3rd Course of the International Society of Surgery and Oncology, International Association of Surgeons, Gastroenterologists and Oncologists (2008)
  • "“Estradiol Induces Export of Sphingosine-1-Phosphate from Human Breast Cancer Cells via ABC Transporters”" The 43rd Annual Southeastern Regional Lipid Conference (2008)
  • "“LC-MS/MS Determination of Sphingolipids in Cell Culture Media" The 43rd Annual Southeastern Regional Lipid Conference (2008)
  • "“The role of ABC transporter in export of sphingosine 1-phosphate from breast cancer cell”" Fifth Annual Interdisciplinary Women’s Health Research Symposium, Office of Women’s Health National Institute of Health (2008)
  • "“The role of ABC transporter in export of sphingosine 1-phosphate from breast cancer cell”" Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) Scholars Meeting, National Institute of Health (2008)
  • "“Treatment of Breast Cancer: Japan vs. U.S.”" 15th Medical Lecture for Japanese Society in Virginia, the Japan-Virginia Society (2008)
  • "“p53 independent Synergistic Effect of Sphingosine Kinase-1 Inhibitor with Irinotecan on Colon Cancer Cell, HCT-116”" The 94th Annual American College of Surgeons Clinical Congress (2008)
  • "“Treatment of Breast Cancer: Japan vs. U.S.”" 14th Medical Lecture for Japanese Society in Virginia, the Japan-Virginia Society (2008)
  • "“ABC Transporters, ABCC1 and ABCG2, but not ABCB1 Export Sphingosine 1-Phosphate from Human Breast Cancer Cells”" The 4th Annual VCUHS Resident Research Day (2008)
  • "“Postgraduate Clinical Training in the U.S. and the Role of Clinicians in Basic Research”" , Niigata University School of Medicine (2008)
  • "“Sphingosine-1-phosphate as a Signaling Molecule and its Relationship with Autophagy”" National Center for Child Health & Development (2008)
  • "“Inhibition of Sphingosine Kinase-1 Using SKI-1 Induce Autophagy”" Virginia Chapter of American College of Surgeons (2008)
  • "“ABC Transporters, ABCC1 and ABCG2, are Involved in Estradiol Induced Export of Sphingosine 1-Phosphate from Human Breast Cancer Cells”" The 99th Annual Meeting of American Association of Cancer Research (2008)
  • "“ABC Transporters, ABCC1 and ABCG2, Export Sphingosine 1-Phosphate from Human Breast Cancer Cells in Response to Estradiol”" The 4th Annual Women’s Health Research Day at Virginia Commonwealth University (2008)
  • "“Autophagy is induced by Sphingosine Kinase Inhibition by SKI-1”" The 25th Annual Seminar of Cancer Researchers in Virginia by American Cancer Society (2007)
  • "“Inhibition of Sphingosine Kinase-1 Using SKI-1 Induce Autophagy”" Virginia Chapter of American College of Surgeon Paper Competition (2007)
  • "“Sphingosine Kinase-1 Inhibition by SKI-1 Induce Autophagy”" The 3rd Annual Integrative cellular and molecular signaling (ICAMS) Research Retreat (2007)
  • "“Advantage of undergoing surgery in the U.S.”" 13th Medical Lecture for Japanese Society in Virginia, the Japan-Virginia Society (2007)
  • "“Surgical Techniques to treat Breast Cancer”" Department of Radiation Oncology, Massey Cancer Center VCU (2007)
  • "“Serum Follistatin Levels Predict the Extent of Liver Regeneration after Hepatectomy”" Virginia Chapter of American College of Surgeons (2007)
  • "“Serum Follistatin Levels Immediately after Hepatectomy Predict the Extent of Liver Regeneration”" 2007 60th Annual Cancer Symposium, the Society of Surgical Oncology (2007)
  • "“Foley for Chole – One Option to avoid Laparoscopic Cholecystectomy Disaster”" 14th International Postgraduate Course of International Society of Surgery and Oncology, International Association of Oncology, International Association of surgeons, Gastroenterologists and Oncologists. (2006)
  • "“Serum Follistatin Levels Predict the Extent of Liver Regeneration after Hepatectomy”" Virginia Chapter of American College of Surgeon Paper Competition (2006)
  • "“Massive lower gastrointestinal bleeding in a patient newly diagnosed with human immunodeficiency virus”" Hunt Annual Meeting of American Gastroenterology Association (2006)
  • "“Postgraduate Training in the United States”" Grand Rounds - Department of Medicine, Toride Kyodo Hospital (2006)
  • "“Surgical Residency in the United States”" National Center for Child Health & Development (2006)
  • "“Hernia Sac Laparoscopy under Spinal Anesthesia for Evaluation of Reduced Incarcerated Inguinal Hernia”" Society of American Gastrointestinal Endoscopic Surgeons (2006)
  • "“The role of Activin and Follistatin in Liver Regeneration”" 9th Yujin Memorial Young Investigator Award Acceptance Lecture, Niigata University School of Medicine (2005)
  • "“Serum Follistatin Levels Predict the Extent of Liver Regeneration after Hepatectomy in Human and Rat Models”" Surgical Forum 2004 Clinical Congress, the American College of Surgeons (2004)
  • "“Activin Inhibits Liver Regeneration from Overgrowing”" Surgical Forum 2003 Clinical Congress, the American College of Surgeons (2003)
  • "“Effects of Massive Liver Removal on Serum Follistatin Levels" The 83rd Annual Meeting of the Endocrine Society (2003)
  • "“Sustained Elevation of Serum Follistatin Level as an Early Predictor of Post-hepatectomy Liver Failure”" San Diego Chapter of the American College of Surgeons, San Diego Society of General Surgeons Spring 2003 (2003)
  • "“Sustained Elevation of Serum Follistatin Level as an Early Predictor of Post-hepatectomy Liver Failure”" San Diego Chapter of the American College of Surgeons and San Diego Society of General Surgeons Spring 2003 (2003)
  • "Artificial Enlargement of the Liver by Suppression of Inhibitory Growth Factor, Activin - A Possible Measure to Solve Donor Liver Shortage-" San Diego Society of General Surgeons Meeting (2002)
  • "“Artificial Enlargement of the Liver by Suppression of Inhibitory Growth Factor, Activin –A Possible Measure to Solve Donor Liver Shortage –“" San Diego Society of General Surgeons Meeting (2002)
  • "“Serum Follistatin Level as an Early Detection Marker of Post-hepatectomy Liver Failure: Using Our Novel Rat 90% Hepatectomy Model”" Society for Surgery of Alimentary Tract, Digestive Disease Week 2001 (2001)
  • "“Adenovirus-mediated Overexpression of Follistatin Results in Enlargement of the Liver in Normal Adult Rats”" The Salk Poster Day (2001)
  • "“Adenovirus-mediated Overexpression of Follistatin Results in Enlargement of the Liver in Normal Adult Rats”" The 51st Annual Meeting of the American Association for the Study of Liver Diseases (2000)
  • "“Adenovirus-mediated Overexpression of Follistatin Enlarge the Intact Liver in Rats.”" The 82nd Annual Meeting of the Endocrine Society (2000)
  • "“Adenovirus-mediated Overexpression of Follistatin Enlarge the Intact Liver in Rats”" The 82nd Annual Meeting of the Endocrine Society (2000)
  • "“Why Cadaveric Transplantations are Rare in Japan”" , University of California San Diego (2000)
  • "“Correction of Hemophilia B with Lentiviral Vectors.”" 2000 Keystone Symposia, Gene Therapy (2000)
  • "“Recombinant Adenovirus Vector Encoding Follistatin: A Potential Tool to Stimulate Liver Regeneration”" The 50th Annual Meeting of the American Association for the Study of Liver Diseases (1999)
  • "“Blockage of Endogenous Activin by Recombinant Adenovirus Vector Encoding Follistatin cDNA”" 1999 North American Inhibin and Activin Congress (1999)
  • "“Postgraduate Training in the United States”" , Yoshida Scholarship Foundation (1999)
  • "“Expression of Activin in Hepatoma Cell Lines and Its Signal Transduction”" The 51st Meeting of Japanese Society of Gastroenterological Surgery (1999)
  • "“Two Cases of Duodenal Ulcer Perforation Retreated Conservatively Following Initial Conservative Therapy”" The 3rd Meeting of Akita Research Association of Conservative Therapy on Peptic Ulcer Perforation (1999)
  • "“Ligand-Dependent Association of Smad2 and Smad3 with the Activin Receptor Complex”" The 80th Annual Meeting of the Endocrine Society (1998)
  • "“Use of an Antisense Oligonucleotide Approach to Assess the Role of Activin as an Anti-Proliferative Agent in the Liver”" The 80th Annual Meeting of the Endocrine Society (1998)
  • "“Cell Growth Effect Using Activin A Antisense Oligonucleotide –Future Drug for Liver Regeneration–“" The 98th Annual Meeting of the Japan Surgical Society (1998)
  • "“Interaction of the Smad Proteins with the Activin Receptor Complex”" McGill University, Endocrine Retreat Program (1998)
  • "“Expression of Activin A and its Suppression During Liver Regeneration – Study using Activin A Antisense Oligo –“" The 10th Annual Meeting of Liver Regeneration Research Meeting (1997)
  • "“Possibility of Activin A Antisense as a Liver Regeneration Accelerator that Enables Extensive Hepatectomy”" The 9th Annual Meeting of Japanese Hepato-Biliary Pancreatic Surgery Society (1997)
  • "“Usefulness of Large Animal Models in Liver Transplantation Studies”" The 9th Annual Meeting of Japanese Hepato-Biliary Pancreatic Surgery Society (1997)
  • "A Case of StrangulatingIntestinal Obstruction Caused by Internal Hernia Due to a Parasite" The 42nd Annual Meeting of Kanagawa Gastroenterological Research Association (1997)
  • "“Activin A Antisense Oligonucleotides Accelerate Hepatic Cell Proliferation”" 1997 Annual Meeting during Digestive Disease Week (1997)
  • "“Activin A and its Antisense Oligonucleotide – As a Marker of Liver Regeneration and as an Accelerator –“" The 97th Annual Meeting of the Japan Surgical Society (1997)
  • "“Activin A Expression and Suppression during Liver Regeneration – Findings using Activin A Antisense Oligo”" The 83rd Annual Meeting during Digestive Disease Week - Japan 1997 (1997)
  • "“Evaluation of Transplanted Liver Viability Using Oxygen Saturation of Hepatic Venous Blood”" The 97th Annual Meeting of the Japan Surgical Society (1997)
  • "“Expression of Activin A mRNA After Hepatectomy – Can it be a Marker of Liver Regeneration?”" The 49th Meeting of Japanese Society of Gastroenterological Surgery (1997)
  • "“Activin A Antisense Oligonucleotides Accelerate Hepatocyte Proliferation”" International Conference on Inhibin, Activin, Follistatin (1996)
  • "“Importance of Serum-MMP2 and 9 Expression as Markers of Colon Cancer”" The 34th Annual Meeting of Japanese Association of Cancer Treatment (1996)
  • "“Analysis of Hemodynamics During Reperfusion in Liver Transplantation”" The 32nd Annual Meeting of the Japan Transplantation Society (1996)
  • "“Study of Minimum Requirement of the Liver and Its Regeneration in Partial Liver Transplantation”" The 32nd Annual Meeting of the Japan Transplantation Society (1996)
  • "Study of Minimum Requirement of the Liver in Partial Liver Transplantation" The 14th Annual Meeting of Liver Transplantation Research Group (1996)
  • "“Postreperfusion Syndrome in Liver Transplantation”" The 14th Annual Meeting of Liver Transplantation Research Group (1996)
  • "Mechanism of Worsening of Postoperative Sepsis and Its /treatnebt" The 21st Meeting of United Surgical Association of Japan (1996)
  • "Postreperfusion Syndrome in Liver Transplantation" The 8th Annual Meeting of Kanagawa Transplantation Research Group. (1996)
  • "“Study of Minimum Requirement of the Liver in Partial Liver Transplantation”" The 96th Annual Meeting of the Japan Surgical Society (1996)
  • "“Complications and Their Treatments of Laparoscopic Cholecystectomy”" The 47th Meeting of Japanese Society of Gastroenterological Surgery (1996)
  • "A Case of Megacolon Complicated with Adrenal Hemochromocytoma" The 237th Meeting of Japanese Society of Gastroenterology, Kanto Division (1995)
  • "“Diagnosis and Treatment of Postoperative Intra-abdominal Infections”" The 8th Annual Meeting of Japanese Surgical Infection Research Association (1995)
  • "A Case of Salmonella Enteritis that Caused Acte Circulatory Failure after Breast Cancer Chemotherapy" The 83rd Meeting of Kanagawa Clinical Surgery Society (1995)
  • "Complication and its Treatment of Laparoscopic Cholecystectomy" The 2nd Meeting of Kanagawa Postoperative Metabolism and Nutrition Research Group (1995)
  • "Outcome of the Treatment of Thyroid Cancer Recurrence" The 31st Meeting of Akita Clinical Surgery Meeting (1995)
  • "Usefulness of Gastrostomy in Postoperative Care" The 30th Meeting of Akita Clinical Surgery Meeting (1994)
See all (305 more)
Service Activities:
  • Professional Service; Society of University Surgeons; Committee Member (2016–2018)
  • Articles; wjg/2013/005982, wjg/2012/033511, wjg/2012/033175, wjg/2012/032558, wjg/2012/032339, wjg/2012/032161, wjg/2012/031958, wjg/2012/031722, wjg/2011/031047, wjg/2011/031013, wjg/2011/030837, wjg/2011/030478, wjg/2011/030335, wjg/2011/029913, wjg/2011/029902, wjg/2011/029377, wjg/2011/028767, wjg/2010/028014, wjg/2010/027910, wjg/2010/027763, wjg/2010/026226, wjg/2010/025873, wjg/2010/025417, wjg/2010/024754, wjg/2010/024577, wjg/2010/024378, wjg/2010/024102, wjg/2010/023654, wjg/2009/023192, wjg/2009/02271; Editorial Board Member (2015–present)
  • Frontiers in Oncology; Editorial Board Member (2015–present)
  • Professional Service; Association for Academic Surgery Publication Committee Member; Committee Member (2015–2017)
  • Professional Service; American Society of Clinical Oncology; Committee Member (2015–present)
  • Professional Service; Edorium Journal of Surgery; Editor-In-Chief (2015–present)
  • Service to the Department; Department of Surgery Research Task Force; Co-Director (2014–present)
  • Service to Profession; Global Affairs Committee Member Association for Academic Surgery; Committee Member (2013–2015)
  • Professional Service; Southeast Regional Lipid Conference; President (2013–2014)
  • Service to Profession; Journal of Surgery and Science; Editor-In-Chief (2013–present)
  • Service to the Institution; Alternate University Faculty Senate (2012–2014)
  • Service to Profession; Association for Academic Surgery; Committee Member (2011–2013)
  • Service to Community; Principal of Richmond Saturday Japanese School (volunteer faculty) Principal was responsible for managing the organization of the school including teachers to conduct Japanese education in Richmond, VA; Principal (2011–2012)
  • Service to the Institution; Alternate IRB committee member (2011–2012)
  • Service to Profession; NSABP (National Surgical Adjuvant Breast and Bowel Project); Member (2011–present)
  • Service to Profession; Session Modulator, South Eastern Regional Lipid Conference (2010–present)
  • Service to Profession; Noguchi Summer Medical School Kameda General Hospital, Chiba, Japan; Visiting Professor (2009)
  • Service to Profession; South Eastern Regional Lipid Conference; Committee Member (2009–2011)
  • Service to Profession; Editorial Board on World Journal of Gastroenterology; Hepatogastoenterology, Journal of Thoracic Disease and Gland Surgery. Academic Editor of the journal, , PLoS ONE; Editorial Board Member (2009–present)
  • Clinical - Outpatient Service; Private outpatient Clinic at VCU Medical Center (2008–present)
  • Clinical Service - Outpatient; Indulgent + Inmate Clinic at VCU Medical Center (2008–present)
  • Clinical Service,Out; Outpatient Surgery at VCU Medical Center (2008–present)
  • Inpatient Service; Consult Attending, Ave. 7 days per month; Consultant (2008–present)
  • Inpatient Service; Ward Attending, average 3-10 dyas (2008–present)
  • Service to Profession; International Medical Graduates Advisors Network Educational Commission for Foreign Medical Graduates (ECFMG); Advisor (2007–present)
  • Service to Profession; International Association of Surgeons, Gastroenterologists and Oncologists (Permanent Faculty); Visiting Professor (2006–present)
  • Service to Profession; Member of Research/Education Committee American Hepato-Pancreato-Biliary Association; Committee Member (2003–2007)
  • Service to Profession; Society of Research Fellows Committee Member The Salk Institute for Biological Studies; Committee Member (1999–2001)
  • Service to School/University/Institution; Thanksgiving Reception for Staff Partners, Alliance foundation of RPCI (45 Lincolin Pkwy, Buffalo)
  • Service to School/University/Institution; Reception for Dr. Reubin Harris, a guest scientist from HHMI/U MN (RPCI0
  • Service to the Institution/Univ./School; Visit from Cayuga Medical Center at Ithaca (RPCI); Participant
  • Service to Institution; Writing Winning Grant Proposals, Grant Writers' Seminar, Lauren Broyles (RPCI)
  • Service to the Institution; Presentation on Breast Cancer Care at RPCI Amberleigh Retirement Community (Williamsville, NY); Presentor
  • Service to the Institution; Press Conference on CIMAvax Announcement (RPCI)
  • Service to Institution; ARTrageous affair Breast Cancer Gala Beast Cancer Colition of Rochester (Holiday Inn Rochester Downtown)
  • Service to Institution; Pegula Sports & Entertainment visit (RPCI)
  • Service to the Institution; Great Lakes Breast Cancer Symposium, University of Pittsburgh Cancer Institute, Cancer Pavilion (UPMC, PA); Participant
  • Service to the Institution; BNMC Translational Genomics and Epigenomics Symposium Buffalo Niagara Medical Complex (RPCI)
  • Service to the Institution; Cancer Stem Cell Conference 2016 Case Western Reserve University (Cleveland, OH); Participant
  • Service to the Institution; Summit for Perfusion Imaging and Excellence in Surgery (sSPIES) 2016 NOVADAQ (Las Vegas, NV); Participant
  • Service to the Institution; 2016 AAMC Grant Writers Coaching Group for NIH Awards American Association of Medical Colleges (San Antonio, Tx); Participant
  • Service to the Institution; Presentation on Vision of RPCI Breast Surgery Division Buffalo Sabres Alumni Luncheon (RPCI); Presentor
  • Service to the Institution; 2016 Breast Cancer Motorcycle Ride, Hosted by Governor Andrew Cuomo (Canalside); Participant
  • Service for the Institution; Cancer Moonshot Summit with Vice President Joe Biden (RPCI); Participant
  • Service to the Institution; RPCI participation in New York State Patient Navigation in Breast Cancer Screening Program (on line); Presentor
  • Service to the Institution; Nipple Sparing Mastectomy: A Team Approach, Medtronic hands-on session (Rosemont, IL); Presentor
  • Service to the Department; VCU Department of Surgery Research Day; Judge
  • Service to Community; Medical Seminar for Japanese in Virginia; "What is wrong being fat?" Japan-Virginia Society (Newport News, VA); Guest Lecturer
  • Service to the Department; Presenter of Research Award at the Bigger Dinner, VCU Surgery; Presentor
  • Service to the Department; VCU Department of Surgery Research Day; Judge
  • Service to the Institution; Modulator/Mentor (Research 4 Residents and Fellows Series, Office of Graduate Education); Participant
  • Service to the Institution; Poster Judge, 12th Annual VCUHS Resident/Fellow Research Day; Judge
  • Service to the Institution; Establishment of medical student visiting/observation program with Tokyo Medical Univ(Organization of courtesy visit by TMU Leadership 4/23/2015)ersity, Japan
  • Service to the Institution; PhD student interview, Urszula Warncke for Cancer and Molecular Medicine concentration in the Clinical and Translational Science program
  • Service to the Department; VCU Department of Surgery Research Day; Judge
  • Service to the Institution; Tissue & Data Acquisition & Analysis Core (TDAAC) Policies and Utilization Review Committee member
  • Service to the Institution; Cancer Informatics Core Advisory Committee member; Committee Member
  • Service to the Institution; General Surgery Residency Program Evaluation Committee (PEC) member
  • Service to the Institution; Surgical Oncology Fellowship Program Evaluation Committee member; Committee Member
  • Service to the Institution; Accreditation Council for Graduate Medical Education (ACGME) Clinical Learning Environment Review (CLER) visit Division Representative
  • Service to the Institution; Lecturer (BIOL410 Cancer Biology Course); Guest Lecturer
  • Service to the Institution; Modulator (Research 4 Residents and Fellows Series, Office of Graduate Education)
  • Service to the Institution; Faculty Search Committee member (Director of Lipidomics Core)
  • Service to Community; Invited Lecture at Saturday Enrichment Program for Gifted Learners, Center for Gifted Education, College of William and Mary (Richmond, VA); Guest Lecturer
  • Service to Community; Medical Seminar for Japanese in Virginia; “What is wrong being fat?” Japan-Virginia Society (Newport News, VA); Participant
  • Service to Community; Invited Lecture at Richmond Saturday Japanese School; Guest Lecturer
  • Service to the Community; Discovery Dialogue "Discovering How Research Helps Fight Breast Cancer" Discovery Dialogue is a lecture series held by VCU junior faculty volunteers for lay audience visiting VCU Medical Center. This presentation was evaluated as 4.6 out of 5 by the audience attended.; Presentor
  • Service to Community; Medical Seminar for Japanese in Virginia; "Treatment of Breast Cancer; Japan vs. U.S." Japan-Virginia Society (Richmond, VA); Participant
  • Service to Community; Medical Seminar for Japanese in Virginia; “Treatment of Breast Cancer: Japan vs. U.S.” Japan-Virginia Society (Richmond, VA); Participant
  • Service to Public; Medical Seminar for Japanese in Virginia; “Advantage of undergoing surgery in the U.S.” Japan-Virginia Society (Newport News, VA); Participant
  • Service to Institution; Presentation Coaching Session by Stephanie Barnard (RPCI)

School News:
In the Media:

Clinical Specialties:
Clinical Offices:
Insurance Accepted:


Contact Information

Surg Roswell Park Cancer Institute
Elm & Carlton St.
Buffalo, NY 14263
Phone: 716-845-5540
Fax: 716-845-5705
Email: kazuakit@buffalo.edu


Log in to Update Your Profile